How much do clinical trials pay?
How we make money: when you sign up for an offer we recommend, we may earn a commission. It costs you nothing extra, and it never decides what makes the list — more on how this works.
Paid clinical trials pay from about $150 to $13,000 per study, with a median of $3,070 — those figures come from the largest published analysis of Phase 1 trials in the U.S. How much you actually get comes down to three things: the trial’s phase, how long it runs, and what it asks of your body. Short outpatient studies pay a few hundred dollars. Long inpatient trials where you stay overnight can pay several thousand. Here’s how it really breaks down — including the parts the recruitment ads tend to skip.
The short answer: typical pay ranges
Compensation varies more than almost any other “get paid for your time” opportunity, so any single number is misleading. The best data available comes from a 2021 study in the journal Clinical Trials (Fisher et al.), which tracked participants screening for 1,001 clinical trials at 73 research facilities over three years. Here’s how those trials actually paid:
- Under $2,000: 22.9% of trials
- $2,000–$4,000: 42.3% — the single most common band
- Over $6,000: 14.7%
The two extremes in that data show clearly what you’re really being paid for. The lowest-paying study was a $150 vaccine trial that required no overnight stay at all. The highest was a $13,000 cancer study that asked healthy volunteers to spend 34 consecutive days and nights in a research clinic. The median across everything was $3,070.
The same study found that healthy volunteers who do these regularly earn roughly $4,000 a year from them — and that earning more than $20,000 in a year was, in the researchers’ words, exceedingly rare.
One caveat that matters: this research looked specifically at Phase 1 trials, where healthy volunteers and the highest payments are concentrated. Later-phase studies are a different picture — more on that below.
What actually determines how much you get paid
1. The trial phase
This is the biggest single factor. Phase 1 trials pay the most — they’re the first tests in humans, usually need healthy volunteers, and often involve inpatient stays with round-the-clock monitoring. That’s why the figures above, which cover Phase 1 specifically, sit as high as they do. Later-stage trials (Phase 2, 3, and 4) test treatments that are already better understood and ask less of participants, so they generally pay less, often substantially less. We haven’t found a published dataset for later-phase payments that we’d stand behind, so we’re not going to invent a number for them — ask the study coordinator directly instead.
Higher pay in early-phase trials isn’t a bonus — it’s compensation for greater unknowns. That trade-off is the whole point to understand before signing up.
2. Time and commitment
You’re paid for what the study asks of you. The things that push compensation up:
- Overnight or multi-day inpatient stays (you’re on-site, monitored around the clock)
- Multiple visits over weeks or months
- Procedures like repeated blood draws, fasting, or imaging
A study that takes a couple of hours pays like it. A study that confines you to a research unit for a week pays like that. Confinement is the clearest single driver in the Fisher data: studies needing no overnight stay clustered at the bottom of the range, and the highest-paying study in the entire dataset was also the one demanding the longest stay.
How and when you actually get paid
Compensation usually isn’t one lump sum at the end. Most trials pay per completed visit, often loaded onto a reloadable debit-style card, so you’re paid as you go. Many studies also include a completion bonus for finishing the full protocol.
It’s worth separating two different things trials offer:
- Compensation — payment for your time and effort. This is the “how much do trials pay” figure.
- Reimbursement — covering your costs (travel, parking, sometimes childcare). This isn’t income; it’s just getting your expenses back.
Some studies offer only reimbursement, not compensation. Read which one you’re being offered before you assume there’s a paycheck.
Is it actually worth it? The honest version
The dollar figures are real, but “get paid to do a clinical trial” leaves a lot out. Before you count on the money:
- You have to qualify. Trials screen hard for specific criteria — age, health status, medications, medical history. Getting screened out after applying (sometimes after a first visit) is common, and the money only comes if you’re accepted and complete the study.
- There are real risks, especially in early-phase trials testing something new. That’s what the higher pay reflects — worth understanding fully before you enroll, and we cover it properly in are paid clinical trials safe?
- It’s not steady income. In the Fisher study, 75.1% of participants earned less than $10,000 from trials in a given year, and even the top 10% of earners had a median annual trial income of $18,885. This is supplemental money, not a salary.
- Payment is tied to completion. Drop out early and you may only get partial pay.
None of that makes trials a bad option — for the right person they’re a legitimate way to earn meaningful money for your time. It just isn’t the effortless windfall the recruitment ads imply, and knowing that up front is how you avoid disappointment.
How to find paid clinical trials
Legitimate trials are listed on registries like ClinicalTrials.gov (the U.S. government database) and through research centers and recruiters near you. Not every listing is compensated, and “paid” studies vary widely in what they offer — so it’s worth knowing how to tell the well-paying, legitimate ones apart before you sign up for anything. Our full walkthrough is here: how to find and join paid clinical trials near you.